Switch to: References

Add citations

You must login to add citations.
  1. The Duty to Disclose Adverse Clinical Trial Results.S. Matthew Liao, Mark Sheehan & Steve Clarke - 2009 - American Journal of Bioethics 9 (8):24-32.
    Participants in some clinical trials are at risk of being harmed and sometimes are seriously harmed as a result of not being provided with available, relevant risk information. We argue that this situation is unacceptable and that there is a moral duty to disclose all adverse clinical trial results to participants in clinical trials. This duty is grounded in the human right not to be placed at risk of harm without informed consent. We consider objections to disclosure grounded in considerations (...)
    Download  
     
    Export citation  
     
    Bookmark   10 citations  
  • Consent and informational responsibility.Shaun D. Pattinson - 2009 - Journal of Medical Ethics 35 (3):176-179.
    The notion of “consent” is frequently referred to as “informed consent” to emphasise the informational component of a valid consent. This article considers aspects of that informational component. One misuse of the language of informed consent is highlighted. Attention is then directed to some features of the situation in which consent would not have been offered had certain information been disclosed. It is argued that whether or not such consent is treated as sufficiently informed must, from a moral point of (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Defining the Boundaries of a Right to Adequate Protection: A New Lens on Pediatric Research Ethics.David DeGrazia, Michelle Groman & Lisa M. Lee - 2017 - Journal of Medicine and Philosophy 42 (2):132-153.
    We argue that the current ethical and regulatory framework for permissible risk levels in pediatric research can be helpfully understood in terms of children’s moral right to adequate protection from harm. Our analysis provides a rationale for what we propose as the highest level of permissible risk in pediatric research without the prospect of direct benefit: what we call “relatively minor” risk. We clarify the justification behind the usual standards of “minimal risk” and “a minor increase over minimal risk” and (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations